Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mayan Pigments was a materials science company that specialized in the development of high-performance, non-toxic hybrid pigments for the cosmetics and specialty chemicals industries. Utilizing a proprietary platform inspired by ancient "Maya Blue" technology, the company bonded organic dyes to inorganic clay templates to create exceptionally stable and environmentally friendly colorants. The company's products were designed as sustainable alternatives to traditional pigments containing heavy metals, targeting applications in FDA-regulated markets such as personal care and cosmetics. Its technology was supported by the National Institute of Environmental Health Sciences (NIEHS) through SBIR grants focused on green chemistry and consumer safety. Although the company is no longer active, its work represented a significant intersection of nanotechnology, green chemistry, and dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mayan Pigments.